• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中央淋巴结比率可预测N1b型乳头状甲状腺癌患者的复发情况。

Central Lymph Node Ratio Predicts Recurrence in Patients with N1b Papillary Thyroid Carcinoma.

作者信息

Kang Il Ku, Kim Kwangsoon, Park Joonseon, Bae Ja Seong, Kim Jeong Soo

机构信息

Department of Surgery, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.

出版信息

Cancers (Basel). 2022 Jul 28;14(15):3677. doi: 10.3390/cancers14153677.

DOI:10.3390/cancers14153677
PMID:35954338
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9367408/
Abstract

The lymph node ratio (LNR) indicates the number of metastatic lymph nodes (LNs) to the total number of LNs. The prognostic value of LNR in papillary thyroid carcinoma (PTC) and other solid tumors is known. This study aimed to investigate the relationship between LNR and disease-free survival (DFS) in patients with PTC with lateral LN metastases (N1b PTC). A total of 307 patients with N1b PTC who underwent total thyroidectomy and therapeutic central and lateral LN dissection were retrospectively analyzed. The DFS and recurrence risk in the patients with LNR, central-compartment LNR (CLNR), and lateral-compartment LNR (LLNR) were compared. The mean follow-up duration was 93.6 ± 19.9 months. Eleven (3.6%) patients experienced recurrence. Neither LNR nor LLNR affected the recurrence rate in our analysis ( 0.058, 0.106, respectively). However, there was a significant difference in the recurrence rates between the patients with low and high CLNR (2.1% vs. 8.8%, 0.017). In the multivariate analysis, CLNR ≥ 0.7 and perineural invasion were independent predictors of tumor recurrence. High CLNR was associated with an increased risk of recurrence, and was shown to be a significant predictor of prognosis in patients with N1b PTC.

摘要

淋巴结比率(LNR)指转移淋巴结(LN)数量与总淋巴结数量之比。LNR在甲状腺乳头状癌(PTC)及其他实体瘤中的预后价值已为人所知。本研究旨在探讨LNR与伴有侧方淋巴结转移的PTC患者(N1b PTC)无病生存期(DFS)之间的关系。对307例行甲状腺全切除术及治疗性中央区和侧方淋巴结清扫术的N1b PTC患者进行回顾性分析。比较LNR、中央区淋巴结比率(CLNR)和侧方区淋巴结比率(LLNR)患者的DFS及复发风险。平均随访时间为93.6±19.9个月。11例(3.6%)患者出现复发。在我们的分析中,LNR和LLNR均未影响复发率(分别为0.058和0.106)。然而,CLNR低和高的患者之间复发率存在显著差异(2.1%对8.8%,P = 0.017)。在多因素分析中,CLNR≥0.7和神经侵犯是肿瘤复发的独立预测因素。高CLNR与复发风险增加相关,并且被证明是N1b PTC患者预后的重要预测因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db1e/9367408/e24b468cee64/cancers-14-03677-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db1e/9367408/6713348cf618/cancers-14-03677-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db1e/9367408/e24b468cee64/cancers-14-03677-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db1e/9367408/6713348cf618/cancers-14-03677-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db1e/9367408/e24b468cee64/cancers-14-03677-g002.jpg

相似文献

1
Central Lymph Node Ratio Predicts Recurrence in Patients with N1b Papillary Thyroid Carcinoma.中央淋巴结比率可预测N1b型乳头状甲状腺癌患者的复发情况。
Cancers (Basel). 2022 Jul 28;14(15):3677. doi: 10.3390/cancers14153677.
2
Optimal value of lymph node ratio and metastatic lymph node size to predict risk of recurrence in pediatric thyroid cancer with lateral neck metastasis.颈侧区淋巴结转移的儿童甲状腺癌中预测复发风险的淋巴结比值和转移淋巴结大小的最佳值。
J Pediatr Surg. 2023 Mar;58(3):568-573. doi: 10.1016/j.jpedsurg.2022.07.010. Epub 2022 Jul 13.
3
Optimal Cut-Off Values of Lymph Node Ratio Predicting Recurrence in Papillary Thyroid Cancer.预测甲状腺乳头状癌复发的淋巴结比率的最佳临界值
Medicine (Baltimore). 2016 Feb;95(5):e2692. doi: 10.1097/MD.0000000000002692.
4
Lymph node ratio predicts recurrence in pediatric papillary thyroid cancer.淋巴结比率可预测儿童乳头状甲状腺癌的复发情况。
J Pediatr Surg. 2019 Jan;54(1):129-132. doi: 10.1016/j.jpedsurg.2018.10.010. Epub 2018 Oct 5.
5
Number of Metastatic Lymph Nodes and Ratio of Metastatic Lymph Nodes to Total Number of Retrieved Lymph Nodes Are Risk Factors for Recurrence in Patients With Clinically Node Negative Papillary Thyroid Carcinoma.转移性淋巴结数量及转移性淋巴结与所切除淋巴结总数的比值是临床淋巴结阴性的乳头状甲状腺癌患者复发的危险因素。
Clin Exp Otorhinolaryngol. 2018 Mar;11(1):58-64. doi: 10.21053/ceo.2017.00472. Epub 2017 Oct 17.
6
PROGNOSTIC VALUE OF LYMPH NODE UPTAKE ON PRETREATMENT F-18 FDG PET/CT IN PATIENTS WITH N1B PAPILLARY THYROID CARCINOMA.N1b 期滤泡状甲状腺癌患者术前 F-18 FDG PET/CT 淋巴结摄取的预后价值。
Endocr Pract. 2019 Aug;25(8):787-793. doi: 10.4158/EP-2018-0607. Epub 2019 Apr 23.
7
Lymph node ratio predicts recurrence in papillary thyroid cancer.淋巴结比率可预测甲状腺乳头状癌的复发。
Oncologist. 2013;18(2):157-62. doi: 10.1634/theoncologist.2012-0240. Epub 2013 Jan 23.
8
Lymph node ratio as a tool to stratify patients with N1b papillary thyroid cancer.淋巴结比率作为 N1b 期甲状腺乳头状癌患者分层的工具。
Langenbecks Arch Surg. 2023 Aug 16;408(1):315. doi: 10.1007/s00423-023-03033-w.
9
Lymph node ratio of the central compartment is a significant predictor for locoregional recurrence after prophylactic central neck dissection in patients with thyroid papillary carcinoma.甲状腺乳头状癌患者预防性中央区颈清扫术后,中央区淋巴结比值是局部区域复发的重要预测指标。
Ann Surg Oncol. 2014 Jan;21(1):277-83. doi: 10.1245/s10434-013-3258-1. Epub 2013 Sep 5.
10
Pre-ablation stimulated thyroglobulin is a better predictor of recurrence in pathological N1a papillary thyroid carcinoma than the lymph node ratio.消融术前刺激甲状腺球蛋白比淋巴结比率更能预测病理N1a期甲状腺乳头状癌的复发。
Int J Clin Oncol. 2016 Oct;21(5):862-868. doi: 10.1007/s10147-016-0956-2. Epub 2016 Feb 2.

引用本文的文献

1
Impact of positive lymph nodes and RAI therapy on survival in N1b papillary thyroid carcinoma.阳性淋巴结及放射性碘治疗对N1b型乳头状甲状腺癌患者生存的影响
Front Endocrinol (Lausanne). 2025 May 22;16:1551075. doi: 10.3389/fendo.2025.1551075. eCollection 2025.
2
Potential functions and mechanisms of lysine crotonylation modification (Kcr) in tumorigenesis and lymphatic metastasis of papillary thyroid cancer (PTC).赖氨酸巴豆酰化修饰(Kcr)在甲状腺乳头状癌(PTC)发生和淋巴转移中的潜在功能和机制。
J Transl Med. 2024 Sep 29;22(1):874. doi: 10.1186/s12967-024-05651-4.
3
Machine learning algorithms for identifying contralateral central lymph node metastasis in unilateral cN0 papillary thyroid cancer.

本文引用的文献

1
Frozen section analysis of central lymph nodes in papillary thyroid cancer: the significance in determining the extent of surgery.甲状腺乳头状癌中央区淋巴结的冰冻切片分析:对确定手术范围的意义
Gland Surg. 2022 Apr;11(4):640-650. doi: 10.21037/gs-22-15.
2
The Prognosis of Skip Metastasis in Papillary Thyroid Microcarcinoma Is Better Than That of Continuous Metastasis.甲状腺微小乳头状癌跳跃性转移的预后优于连续性转移。
J Clin Endocrinol Metab. 2022 May 17;107(6):1589-1598. doi: 10.1210/clinem/dgac107.
3
Level IIb neck dissection guided by fine-needle aspiration for N1b papillary thyroid carcinoma.
用于识别单侧 cN0 甲状腺乳头状癌中央淋巴结转移的机器学习算法。
Front Endocrinol (Lausanne). 2024 May 10;15:1385324. doi: 10.3389/fendo.2024.1385324. eCollection 2024.
4
Assessing the role of central lymph node ratio in predicting recurrence in N1a low-to-intermediate risk papillary thyroid carcinoma.评估中央淋巴结比值在预测 N1a 低-中危甲状腺乳头状癌复发中的作用。
Front Endocrinol (Lausanne). 2023 Sep 14;14:1158826. doi: 10.3389/fendo.2023.1158826. eCollection 2023.
5
Nomogram to predict the risk of biochemical recurrence and structural recurrence in patients with stage cN1 papillary thyroid carcinoma.列线图预测 cN1 期甲状腺乳头状癌患者生化复发和结构复发的风险。
J Cancer Res Clin Oncol. 2023 Oct;149(13):11073-11083. doi: 10.1007/s00432-023-04998-3. Epub 2023 Jun 20.
6
Lymph Node Ratio Predicts Recurrence in Patients with Papillary Thyroid Carcinoma with Low Lymph Node Yield.淋巴结比率可预测低淋巴结转移率的乳头状甲状腺癌患者的复发情况。
Cancers (Basel). 2023 May 27;15(11):2947. doi: 10.3390/cancers15112947.
超声引导下细针穿刺活检 N1b 期甲状腺乳头状癌行 IIb 区颈部淋巴结清扫术。
Surg Oncol. 2022 Mar;40:101705. doi: 10.1016/j.suronc.2021.101705. Epub 2021 Dec 30.
4
Lymph node ratio is superior to AJCC N stage for predicting recurrence in papillary thyroid carcinoma.在预测甲状腺乳头状癌复发方面,淋巴结比率优于美国癌症联合委员会(AJCC)的N分期。
Endocr Connect. 2022 Feb 16;11(2):e210518. doi: 10.1530/EC-21-0518.
5
Prognostic Value of Lymph Node Ratio in Cutaneous Melanoma: A Systematic Review.淋巴结比率在皮肤黑色素瘤中的预后价值:一项系统评价
Cureus. 2021 Oct 29;13(10):e19117. doi: 10.7759/cureus.19117. eCollection 2021 Oct.
6
A worldwide journey of thyroid cancer incidence centred on tumour histology.以肿瘤组织学为核心的全球甲状腺癌发病率研究之旅。
Lancet Diabetes Endocrinol. 2021 Apr;9(4):193-194. doi: 10.1016/S2213-8587(21)00049-8. Epub 2021 Mar 1.
7
Metastatic lymph node ratio as a better prognostic tool than the TNM system in colorectal cancer.转移性淋巴结比率是比结直肠癌的 TNM 系统更好的预后工具。
Future Oncol. 2021 Apr;17(12):1519-1532. doi: 10.2217/fon-2020-0993. Epub 2021 Feb 25.
8
Lymph Node Ratio Predicts Long-Term Survival in Lymph Node-Positive Breast Cancer.淋巴结比率可预测淋巴结阳性乳腺癌的长期生存情况。
Eur J Breast Health. 2020 Jul 29;16(4):270-275. doi: 10.5152/ejbh.2020.5809. eCollection 2020 Oct.
9
Innervation of papillary thyroid cancer and its association with extra-thyroidal invasion.甲状腺乳头状癌的神经支配及其与甲状腺外侵犯的关系。
Sci Rep. 2020 Jan 30;10(1):1539. doi: 10.1038/s41598-020-58425-5.
10
Clinical Value of Lymph Node Ratio Integration with the 8 Edition of the UICC TNM Classification and 2015 ATA Risk Stratification Systems for Recurrence Prediction in Papillary Thyroid Cancer.淋巴结比与第 8 版 UICC TNM 分类和 2015 年 ATA 风险分层系统联合用于预测甲状腺乳头状癌复发的临床价值。
Sci Rep. 2019 Sep 16;9(1):13361. doi: 10.1038/s41598-019-50069-4.